Tilray Brands (TLRY) EBIT (2017 - 2026)
Tilray Brands (TLRY) reported EBIT of -$26.4 million for Q1 2026, up 96.53% on a YoY basis from -$13.4 million in Q1 2025, and down 18.43% quarter-over-quarter from -$22.3 million in Q4 2025.
Tilray Brands (TLRY) EBIT (2017 - 2026) Analysis & Trends
Tilray Brands has reported EBIT for 10 years, with the latest figure at -$26.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 96.53% year-over-year to -$26.4 million; the trailing twelve-month figure through Feb 2026 stood at -$1.5 billion (down 74.28% YoY), and the FY2025 full-year result was -$2.3 billion, down 1206.31% from the prior year.
- EBIT for Q1 2026 stood at -$26.4 million, down from -$22.3 million in the prior quarter.
- The five-year high for EBIT was $2.1 million in Q3 2025, with the low at -$1.4 billion in Q2 2025.
- Historically, EBIT has averaged -$256.4 million across 5 years, with a median of -$41.8 million in 2023.
- The largest YoY upside for EBIT was 105.72% in 2025 against a maximum downside of 8637.66% in 2025.
- Tilray Brands' EBIT stood at -$51.8 million in 2022, then grew by 19.37% to -$41.8 million in 2023, then decreased by 1.1% to -$42.2 million in 2024, then soared by 47.23% to -$22.3 million in 2025, then dropped by 18.43% to -$26.4 million in 2026.
- The last three EBIT figures came in at -$26.4 million (Q1 2026), -$22.3 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | -26.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -26.39 Mn |
| Nov 30, 2025 | -22.28 Mn |
| Aug 31, 2025 | 2.09 Mn |
| May 31, 2025 | -1.44 Bn |
| Feb 28, 2025 | -759.93 Mn |
| Nov 30, 2024 | -42.22 Mn |
| Aug 31, 2024 | -36.57 Mn |
| May 31, 2024 | -16.53 Mn |
| Feb 29, 2024 | -82.10 Mn |
| Nov 30, 2023 | -41.76 Mn |
| Aug 31, 2023 | -34.36 Mn |
| May 31, 2023 | -89.98 Mn |
| Feb 28, 2023 | -1.21 Bn |
| Nov 30, 2022 | -51.79 Mn |
| Aug 31, 2022 | -21.18 Mn |
| May 31, 2022 | -467.42 Mn |
| Feb 28, 2022 | -18.08 Mn |
| Nov 30, 2021 | -55.53 Mn |
| Aug 31, 2021 | -69.37 Mn |
| May 31, 2021 | -13.92 Mn |